One of the most significant findings in GHK-Cu research is its effect on gene expression. A 2014 genomic study by Campbell et al. analyzed GHK-Cu's impact on the expression of 54,675 genes using microarray analysis of human facial fibroblast cell cultures. The study found that GHK-Cu significantly modulated 4,048 genes — approximately 7.4% of the human genome.³

Among the modulated genes, GHK-Cu upregulated genes involved in tissue repair, collagen synthesis, antioxidant defense, and anti-inflammatory pathways. It simultaneously downregulated genes associated with tissue destruction, inflammation, and fibrosis. The breadth of this gene expression modulation is unusual for a small tripeptide and suggests that GHK-Cu influences fundamental cellular regulatory networks rather than a single pathway.

GHK-Cu has been studied in various wound healing models. In rat studies, topical application of GHK-Cu accelerated wound closure, increased angiogenesis (blood vessel formation) at the wound site, and improved the quality of regenerated tissue compared to controls. The compound also showed activity in bone repair models, where it promoted osteoblast activity and mineral deposition.⁴

The wound healing effects are thought to involve multiple mechanisms: copper delivery to metalloenzymes (such as lysyl oxidase, which cross-links collagen), direct stimulation of growth factor expression, and recruitment of immune cells and fibroblasts to the injury site.

GHK-Cu has shown antioxidant properties in cell culture models, including the ability to reduce iron-induced lipid peroxidation and protect cells from oxidative stress. The copper component of GHK-Cu participates in superoxide dismutase activity, and the peptide itself has been shown to upregulate genes encoding antioxidant enzymes.⁵

Anti-inflammatory effects have also been observed in cell culture studies, with GHK-Cu reducing the production of pro-inflammatory cytokines including IL-6, TNF-alpha, and TGF-beta in activated immune cell cultures.